B Thewes1, M L Bell, P Butow. 1. Centre for Medical Psychology and Evidence-Based Decision Making, School of Psychology, University of Sydney, Sydney, NSW, Australia. bthewes@usyd.edu.au
Abstract
OBJECTIVE: Fear of cancer recurrence (FCR) is a common challenge of cancer survivorship, particularly in younger survivors. Maladaptive metacognitions have been shown to be important to the development of a range of emotional disorders but have not previously been explored in the context of FCR. AIMS: This study aimed to explore the relationship between FCR and a maladaptive metacognitions. METHODS: This cross-sectional study included young women diagnosed with early-stage breast cancer at least 1 year prior to study entry. Participants completed a web-based questionnaire, which included the Fear of Cancer Recurrence Inventory (FCRI) and the brief Metacognitions Questionnaire-30 (MCQ-30). Linear regression was used to calculate unadjusted and adjusted slope estimates of the association of FCR with six metacognition variables, the total score of the MCQ-30 and the five subscales. RESULTS: Two-hundred and eighteen women with a mean age of 39 years at diagnosis participated. All measures of metacognitive style were moderately correlated with FCRI scores (r=0.31-0.49) and significantly associated with FCRI in both unadjusted and adjusted models. Overall metacognitive style explained 36% of the variance in FCR scores in combination with disease and demographic factors. Negative metacognitions (R(2) =0.32) and need for control over cognition (R(2)=0.26) were the MCQ-30 subscales most associated with higher FCR. CONCLUSIONS: Unhelpful metacognitions appear to play an important role in FCR in young women with early-stage breast cancer. Treatments that focus on changing unhelpful metacognitions may prove a useful approach for treating clinical FCR in cancer survivors in the future.
OBJECTIVE: Fear of cancer recurrence (FCR) is a common challenge of cancer survivorship, particularly in younger survivors. Maladaptive metacognitions have been shown to be important to the development of a range of emotional disorders but have not previously been explored in the context of FCR. AIMS: This study aimed to explore the relationship between FCR and a maladaptive metacognitions. METHODS: This cross-sectional study included young women diagnosed with early-stage breast cancer at least 1 year prior to study entry. Participants completed a web-based questionnaire, which included the Fear of Cancer Recurrence Inventory (FCRI) and the brief Metacognitions Questionnaire-30 (MCQ-30). Linear regression was used to calculate unadjusted and adjusted slope estimates of the association of FCR with six metacognition variables, the total score of the MCQ-30 and the five subscales. RESULTS: Two-hundred and eighteen women with a mean age of 39 years at diagnosis participated. All measures of metacognitive style were moderately correlated with FCRI scores (r=0.31-0.49) and significantly associated with FCRI in both unadjusted and adjusted models. Overall metacognitive style explained 36% of the variance in FCR scores in combination with disease and demographic factors. Negative metacognitions (R(2) =0.32) and need for control over cognition (R(2)=0.26) were the MCQ-30 subscales most associated with higher FCR. CONCLUSIONS: Unhelpful metacognitions appear to play an important role in FCR in young women with early-stage breast cancer. Treatments that focus on changing unhelpful metacognitions may prove a useful approach for treating clinical FCR in cancer survivors in the future.
Authors: Julie M Cessna Palas; Kelly A Hyland; Ashley M Nelson; Brent J Small; Heather S L Jim; Paul B Jacobsen Journal: Support Care Cancer Date: 2020-06-10 Impact factor: 3.603
Authors: Allan 'Ben' Smith; Louise Sharpe; Belinda Thewes; Jane Turner; Jemma Gilchrist; Joanna E Fardell; Afaf Girgis; Stephanie Tesson; Joseph Descallar; Melanie L Bell; Jane Beith; Phyllis Butow Journal: Support Care Cancer Date: 2018-06-07 Impact factor: 3.603
Authors: S Sarkar; A Scherwath; L Schirmer; F Schulz-Kindermann; K Neumann; M Kruse; A Dinkel; S Kunze; F Balck; N Kröger; U Koch; A Mehnert Journal: Bone Marrow Transplant Date: 2014-07-07 Impact factor: 5.483
Authors: Laura B Dunn; Dale J Langford; Steven M Paul; Molly B Berman; Dianne M Shumay; Kord Kober; John D Merriman; Claudia West; John M Neuhaus; Christine Miaskowski Journal: Support Care Cancer Date: 2014-12-19 Impact factor: 3.603